The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities.

Patients with advanced-stage pancreatic ductal adenocarcinoma (PDAC) predominantly receive chemotherapy, and despite initial responses in some patients, most will have disease progression and often dismal outcomes. This lack of clinical effectiveness…

Preview only. Read the full abstract at the source